The Polyunsaturated Fatty Acids EPA and DHA Prevent Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats

The Polyunsaturated Fatty Acids EPA and DHA Prevent Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats

Bibliographic Details
Main Authors:	Yoichi Sunagawa, Ayumi Katayama, Masafumi Funamoto, Kana Shimizu, Satoshi Shimizu, Yasufumi Katanasaka, Yusuke Miyazaki, Koji Hasegawa, Tatsuya Morimoto
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2021-12-01
Series:	European Cardiology Review
Online Access:	https://www.ecrjournal.com/articleindex/ecr.2021.16.PO12

Similar Items

Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes
by: Yoichi Sunagawa, et al.
Published: (2021-10-01)

Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats
by: Yoichi Sunagawa, et al.
Published: (2021-07-01)

Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes
by: Yoichi Sunagawa, et al.
Published: (2018-04-01)

<i>Ecklonia stolonifera</i> Okamura Extract Suppresses Myocardial Infarction-Induced Left Ventricular Systolic Dysfunction by Inhibiting p300-HAT Activity
by: Takahiro Katagiri, et al.
Published: (2022-01-01)

Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases
by: Kana Shimizu, et al.
Published: (2019-07-01)

Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice
by: Yuto Kawase, et al.
Published: (2021-12-01)

6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
by: Yuto Kawase, et al.
Published: (2023-05-01)

Histone Acetylation Domains Are Differentially Induced during Development of Heart Failure in Dahl Salt-Sensitive Rats
by: Masafumi Funamoto, et al.
Published: (2021-02-01)

Serum levels of Cystatin C, a sensitive marker of cardiovascular disease: Decrease after smoking cessation
by: Ayumi Katayama, et al.
Published: (2019-10-01)

A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats
by: Hidemichi Takai, et al.
Published: (2021-12-01)

ANGPTL4 Expression Is Increased in Epicardial Adipose Tissue of Patients with Coronary Artery Disease
by: Yasufumi Katanasaka, et al.
Published: (2022-04-01)

Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay
by: Satoshi Shimizu, et al.
Published: (2021-12-01)

The effect of highly absorbed curcumin on an oxidized LDL in patients with COPD
by: Masafumi Funamoto, et al.
Published: (2019-10-01)

Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice
by: Yoichi Sunagawa, et al.
Published: (2024-02-01)

Neutrophil/lymphocyte ratio is correlated with levels of inflammatory markers and is significantly reduced by smoking cessation
by: Maki Komiyama, et al.
Published: (2021-06-01)

The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
by: Mikuto Tojima, et al.
Published: (2021-12-01)

Chrysanthemum morifolium Extract Prevents the Development of Doxorubicin-induced Heart Failure
by: Masaya Ono, et al.
Published: (2021-12-01)

Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
by: Masafumi Funamoto, et al.
Published: (2022-06-01)

The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2–GATA4 Signaling Pathway
by: Kana Shimizu, et al.
Published: (2021-12-01)

Ameliorating prediabetic subject status via fermented tea supplementation: A randomized, double-blind, parallel-group comparison study
by: Yasufumi Katanasaka, et al.
Published: (2022-10-01)

Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice
by: Yasufumi Katanasaka, et al.
Published: (2024-03-01)

<i>Chrysanthemum morifolium</i> Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis
by: Masaya Ono, et al.
Published: (2022-01-01)

Differentiating EPA from EPA/DHA in cardiovascular risk reduction
by: Peter P. Toth, et al.
Published: (2022-05-01)

Producing Omega-3 Polyunsaturated Fatty Acids: A Review of Sustainable Sources and Future Trends for the EPA and DHA Market
by: Laura Oliver, et al.
Published: (2020-12-01)

Are EPA and DHA Derivatives Involved in IBD Remission?
by: Justyna Kikut, et al.
Published: (2022-04-01)

Marine Cryptophytes Are Great Sources of EPA and DHA
by: Elina Peltomaa, et al.
Published: (2017-12-01)

Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease—Possible Causes and Future Considerations
by: Charalambos Michaeloudes, et al.
Published: (2023-11-01)

Omega-3 Polyunsaturated Fatty Acids EPA and DHA as an Adjunct to Non-Surgical Treatment of Periodontitis: A Randomized Clinical Trial
by: Mirella Stańdo, et al.
Published: (2020-08-01)

Effects of matrix on plasma levels of EPA and DHA in dogs
by: Kay Goffin, et al.
Published: (2017-01-01)

Importance of EPA and DHA Blood Levels in Brain Structure and Function
by: Clemens von Schacky
Published: (2021-03-01)

The Polyunsaturated Fatty Acid EPA, but Not DHA, Enhances Neurotrophic Factor Expression through Epigenetic Mechanisms and Protects against Parkinsonian Neuronal Cell Death
by: Maria Rachele Ceccarini, et al.
Published: (2022-12-01)

The role of dysregulation of glial cells in ageing-associated memory impairment: different effects of omega-3 polyunsaturated fatty acid EPA and DHA treatments
by: Xia Juan, et al.
Published: (2023-04-01)

Markers of neuroprotection of combined EPA and DHA provided by fish oil are higher than those of EPA (Nannochloropsis) and DHA (Schizochytrium) from microalgae oils in Wistar rats
by: Paula A. Lopes, et al.
Published: (2017-09-01)

DHA and EPA levels in a piscivorous fish changed by preying upon stocked salmon fry
by: Koh Hasegawa, et al.
Published: (2023-09-01)

Hepatic Levels of DHA-Containing Phospholipids Instruct SREBP1-Mediated Synthesis and Systemic Delivery of Polyunsaturated Fatty Acids
by: Daisuke Hishikawa, et al.
Published: (2020-09-01)

Supplementation of EPA and DHA in pregnant women with type 1 diabetes mellitus
by: Marina Ivanisevic, et al.
Published: (2021-01-01)

Evaluation of Plasma AA/DHA+EPA Ratio in Obese Romanian Children
by: Huțanu Adina, et al.
Published: (2021-04-01)

The Ocean supplies more EPA and DHA than we can use
by: Ackman R.G.
Published: (2004-03-01)

EPA and DHA containing phospholipids have contrasting effects on membrane structure
by: Samuel C.R. Sherratt, et al.
Published: (2021-01-01)

Effect of prenatal EPA and DHA on maternal and umbilical cord blood cytokines
by: Ellen L. Mozurkewich, et al.
Published: (2018-06-01)